
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $760.5M | -- | -- | $0.09 | -- |
08/01/2025 | Q2 | $718.2M | -- | -- | -$0.00 | -- |
05/07/2025 | Q1 | $793.4M | $776.6M | $0.09 | $0.01 | $0.08 |
02/20/2025 | Q4 | $716.6M | $714.7M | -$0.19 | -$0.10 | -$0.09 |
10/31/2024 | Q3 | $775.5M | $764.7M | -$0.16 | -$0.04 | -$0.13 |
08/01/2024 | Q2 | $755.8M | $767.2M | -$0.18 | -$0.08 | -$0.10 |
05/02/2024 | Q1 | $751.5M | $782.9M | -$0.19 | -$0.06 | -$0.13 |
02/15/2024 | Q4 | $691.3M | $687.1M | -$0.23 | -$0.14 | -$0.09 |
11/02/2023 | Q3 | -- | -- | -$0.61 | -$0.06 | -$0.55 |
08/03/2023 | Q2 | -- | -- | -$0.39 | -$0.23 | -$0.17 |
05/04/2023 | Q1 | -- | -- | -$0.32 | -$0.23 | -$0.09 |
02/15/2023 | Q4 | -- | -- | -$0.50 | -$0.30 | -$0.20 |
11/02/2022 | Q3 | -- | -- | -$0.43 | -$0.25 | -$0.18 |
08/02/2022 | Q2 | -- | -- | -$0.59 | -$0.31 | -$0.28 |
05/03/2022 | Q1 | -- | -- | $0.12 | -$0.34 | $0.46 |
02/15/2022 | Q4 | -- | -- | -$0.60 | -$0.37 | -$0.23 |
11/02/2021 | Q3 | -- | -- | -$0.75 | -$0.55 | -$0.20 |
08/03/2021 | Q2 | -- | -- | -$0.79 | -$0.59 | -$0.20 |
05/04/2021 | Q1 | -- | -- | -$0.84 | -$0.55 | -$0.30 |
02/16/2021 | Q4 | -- | -- | -$0.98 | -$0.66 | -$0.32 |
11/06/2020 | Q3 | -- | -- | -$1.07 | -$0.72 | -$0.35 |
08/07/2020 | Q2 | -- | -- | -$1.61 | -$0.84 | -$0.77 |
05/08/2020 | Q1 | -- | -- | -$0.78 | -$0.32 | -$0.46 |
02/26/2020 | Q4 | -- | -- | $0.04 | $0.16 | -$0.12 |
10/31/2019 | Q3 | -- | -- | $0.23 | $0.24 | -$0.01 |
08/01/2019 | Q2 | -- | -- | $0.24 | $0.22 | $0.02 |
04/30/2019 | Q1 | -- | -- | $0.34 | $0.31 | $0.03 |
02/12/2019 | Q4 | -- | -- | $0.34 | $0.33 | $0.01 |
10/30/2018 | Q3 | -- | -- | $0.39 | $0.35 | $0.04 |
07/31/2018 | Q2 | -- | -- | $0.37 | $0.35 | $0.02 |
05/01/2018 | Q1 | -- | -- | $0.44 | $0.41 | $0.03 |
02/14/2018 | Q4 | -- | -- | $0.32 | $0.28 | $0.04 |
10/31/2017 | Q3 | -- | -- | $0.31 | $0.29 | $0.02 |
08/01/2017 | Q2 | -- | -- | $0.35 | $0.35 | -$0.00 |
05/02/2017 | Q1 | -- | -- | $0.42 | $0.35 | $0.07 |
02/07/2017 | Q4 | -- | -- | $0.25 | $0.28 | -$0.03 |
11/02/2016 | Q3 | -- | -- | $0.14 | $0.21 | -$0.07 |
08/02/2016 | Q2 | -- | -- | $0.26 | $0.25 | $0.01 |
04/28/2016 | Q1 | -- | -- | $0.37 | $0.30 | $0.07 |
02/09/2016 | Q4 | -- | -- | $0.24 | $0.25 | -$0.01 |
10/29/2015 | Q3 | -- | -- | $0.27 | $0.28 | -$0.01 |
Sabre reported $776.6M worth of top line sales in its most recent quarter.
Sabre announced earnings per share of $0.09 which represents a beat of analyst forecast a $0.01 per share.
Sabre reported $246.7M that represents $0.54 per share over the last quarter.
Sabre's earnings are forecast to decrease from -$0.73 per share to -$0.18 per share next year representing a decrease of -88.21%.
Sabre's next earnings date is August 1, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.